1 METHODOLOGY
1.1 OUR APPROACH

2 THE WORLD MARKET
2.1 EXPORTS
2.1.1 THE WORLD MARKET: MEDICAMENTS CONTAINING ANTIBIOTICS (EXCEPT PENICILLINS AND STREPTOMYCINS) EXCLUDING THOSE IN DOSAGE FORM OR RETAIL PACKINGS EXPORT SUPPLIES IN 2022
2.2 IMPORTS
2.2.1 THE WORLD MARKET: IMPORTED MEDICAMENTS CONTAINING ANTIBIOTICS (EXCEPT PENICILLINS AND STREPTOMYCINS) EXCLUDING THOSE IN DOSAGE FORM OR RETAIL PACKINGS IN 2022

3 EXPORTS
3.1 AFRICA: EXPORT SUPPLIES OF MEDICAMENTS CONTAINING ANTIBIOTICS (EXCEPT PENICILLINS AND STREPTOMYCINS) EXCLUDING THOSE IN DOSAGE FORM OR RETAIL PACKINGS IN 2022
3.1.1 EXECUTIVE SUMMARY
3.1.2 DJIBOUTI
3.1.3 EGYPT
3.1.4 GHANA
3.1.5 KENYA
3.1.6 MOROCCO
3.1.7 SOUTH AFRICA
3.1.8 TUNISIA
3.1.9 UGANDA
3.1.10 ZIMBABWE
3.2 ASIA: EXPORT SUPPLIES OF MEDICAMENTS CONTAINING ANTIBIOTICS (EXCEPT PENICILLINS AND STREPTOMYCINS) EXCLUDING THOSE IN DOSAGE FORM OR RETAIL PACKINGS IN 2022
3.2.1 EXECUTIVE SUMMARY
3.2.2 BANGLADESH
3.2.3 CHINA
3.2.4 HONG KONG
3.2.5 INDIA
3.2.6 INDONESIA
3.2.7 JAPAN
3.2.8 MALAYSIA
3.2.9 SINGAPORE
3.2.10 SOUTH KOREA
3.2.11 TAIWAN
3.2.12 THAILAND
3.2.13 THE PHILIPPINES
3.2.14 VIETNAM
3.3 EUROPE: EXPORT SUPPLIES OF MEDICAMENTS CONTAINING ANTIBIOTICS (EXCEPT PENICILLINS AND STREPTOMYCINS) EXCLUDING THOSE IN DOSAGE FORM OR RETAIL PACKINGS IN 2022
3.3.1 EXECUTIVE SUMMARY
3.3.2 AUSTRIA
3.3.3 BELGIUM
3.3.4 BULGARIA
3.3.5 CYPRUS
3.3.6 DENMARK
3.3.7 FRANCE
3.3.8 GERMANY
3.3.9 GREECE
3.3.10 HUNGARY
3.3.11 IRELAND
3.3.12 ITALY
3.3.13 LITHUANIA
3.3.14 MALTA
3.3.15 POLAND
3.3.16 PORTUGAL
3.3.17 ROMANIA
3.3.18 RUSSIA
3.3.19 SLOVAKIA
3.3.20 SLOVENIA
3.3.21 SPAIN
3.3.22 SWEDEN
3.3.23 SWITZERLAND
3.3.24 THE CZECH REPUBLIC
3.3.25 THE NETHERLANDS
3.3.26 THE UNITED KINGDOM
3.3.27 UKRAINE
3.4 LATIN AMERICA: EXPORT SUPPLIES OF MEDICAMENTS CONTAINING ANTIBIOTICS (EXCEPT PENICILLINS AND STREPTOMYCINS) EXCLUDING THOSE IN DOSAGE FORM OR RETAIL PACKINGS IN 2022
3.4.1 EXECUTIVE SUMMARY
3.4.2 ARGENTINA
3.4.3 BRAZIL
3.4.4 COLOMBIA
3.4.5 ECUADOR
3.4.6 GUATEMALA
3.4.7 MEXICO
3.4.8 PANAMA
3.4.9 PERU
3.4.10 URUGUAY
3.5 NORTH AMERICA & THE CARIBBEAN: EXPORT SUPPLIES OF MEDICAMENTS CONTAINING ANTIBIOTICS (EXCEPT PENICILLINS AND STREPTOMYCINS) EXCLUDING THOSE IN DOSAGE FORM OR RETAIL PACKINGS IN 2022
3.5.1 EXECUTIVE SUMMARY
3.5.2 CANADA
3.5.3 THE DOMINICAN REPUBLIC
3.5.4 THE UNITED STATES
3.6 OCEANIA: EXPORT SUPPLIES OF MEDICAMENTS CONTAINING ANTIBIOTICS (EXCEPT PENICILLINS AND STREPTOMYCINS) EXCLUDING THOSE IN DOSAGE FORM OR RETAIL PACKINGS IN 2022
3.6.1 EXECUTIVE SUMMARY
3.6.2 AUSTRALIA
3.6.3 NEW ZEALAND
3.7 THE MIDDLE EAST: EXPORT SUPPLIES OF MEDICAMENTS CONTAINING ANTIBIOTICS (EXCEPT PENICILLINS AND STREPTOMYCINS) EXCLUDING THOSE IN DOSAGE FORM OR RETAIL PACKINGS IN 2022
3.7.1 EXECUTIVE SUMMARY
3.7.2 ISRAEL
3.7.3 JORDAN
3.7.4 SAUDI ARABIA
3.7.5 SYRIA
3.7.6 THE UNITED ARAB EMIRATES
3.7.7 TURKEY

4 IMPORTS
4.1 AFRICA: MEDICAMENTS CONTAINING ANTIBIOTICS (EXCEPT PENICILLINS AND STREPTOMYCINS) EXCLUDING THOSE IN DOSAGE FORM OR RETAIL PACKINGS IMPORTS IN 2022
4.1.1 EXECUTIVE SUMMARY
4.1.2 ALGERIA
4.1.3 BENIN
4.1.4 BOTSWANA
4.1.5 BURUNDI
4.1.6 CAMEROON
4.1.7 COTE D'IVOIRE
4.1.8 EGYPT
4.1.9 ETHIOPIA
4.1.10 MALAWI
4.1.11 MAURITANIA
4.1.12 MOROCCO
4.1.13 MOZAMBIQUE
4.1.14 NAMIBIA
4.1.15 NIGERIA
4.1.16 RWANDA
4.1.17 SENEGAL
4.1.18 SOUTH AFRICA
4.1.19 TANZANIA
4.1.20 UGANDA
4.1.21 ZAMBIA
4.1.22 ZIMBABWE
4.2 ASIA: MEDICAMENTS CONTAINING ANTIBIOTICS (EXCEPT PENICILLINS AND STREPTOMYCINS) EXCLUDING THOSE IN DOSAGE FORM OR RETAIL PACKINGS IMPORTS IN 2022
4.2.1 EXECUTIVE SUMMARY
4.2.2 BRUNEI
4.2.3 CHINA
4.2.4 HONG KONG
4.2.5 INDIA
4.2.6 INDONESIA
4.2.7 JAPAN
4.2.8 MALAYSIA
4.2.9 MONGOLIA
4.2.10 NEPAL
4.2.11 SINGAPORE
4.2.12 SOUTH KOREA
4.2.13 SRI LANKA
4.2.14 TAIWAN
4.2.15 THAILAND
4.2.16 THE PHILIPPINES
4.2.17 VIETNAM
4.3 EUROPE: MEDICAMENTS CONTAINING ANTIBIOTICS (EXCEPT PENICILLINS AND STREPTOMYCINS) EXCLUDING THOSE IN DOSAGE FORM OR RETAIL PACKINGS IMPORTS IN 2022
4.3.1 EXECUTIVE SUMMARY
4.3.2 AUSTRIA
4.3.3 BELARUS
4.3.4 BELGIUM
4.3.5 BULGARIA
4.3.6 CYPRUS
4.3.7 DENMARK
4.3.8 ESTONIA
4.3.9 FINLAND
4.3.10 FRANCE
4.3.11 GERMANY
4.3.12 GREECE
4.3.13 HUNGARY
4.3.14 IRELAND
4.3.15 ITALY
4.3.16 KAZAKHSTAN
4.3.17 LATVIA
4.3.18 LUXEMBOURG
4.3.19 MOLDOVA
4.3.20 NORWAY
4.3.21 POLAND
4.3.22 PORTUGAL
4.3.23 ROMANIA
4.3.24 RUSSIA
4.3.25 SLOVAKIA
4.3.26 SLOVENIA
4.3.27 SPAIN
4.3.28 SWEDEN
4.3.29 SWITZERLAND
4.3.30 THE CZECH REPUBLIC
4.3.31 THE NETHERLANDS
4.3.32 THE UNITED KINGDOM
4.3.33 UKRAINE
4.4 LATIN AMERICA: MEDICAMENTS CONTAINING ANTIBIOTICS (EXCEPT PENICILLINS AND STREPTOMYCINS) EXCLUDING THOSE IN DOSAGE FORM OR RETAIL PACKINGS IMPORTS IN 2022
4.4.1 EXECUTIVE SUMMARY
4.4.2 ARGENTINA
4.4.3 BRAZIL
4.4.4 CHILE
4.4.5 COLOMBIA
4.4.6 EL SALVADOR
4.4.7 GUATEMALA
4.4.8 GUYANA
4.4.9 HONDURAS
4.4.10 MEXICO
4.4.11 NICARAGUA
4.4.12 PANAMA
4.4.13 PARAGUAY
4.4.14 PERU
4.4.15 URUGUAY
4.5 NORTH AMERICA & THE CARIBBEAN: MEDICAMENTS CONTAINING ANTIBIOTICS (EXCEPT PENICILLINS AND STREPTOMYCINS) EXCLUDING THOSE IN DOSAGE FORM OR RETAIL PACKINGS IMPORTS IN 2022
4.5.1 EXECUTIVE SUMMARY
4.5.2 CANADA
4.5.3 JAMAICA
4.5.4 THE UNITED STATES
4.6 OCEANIA: MEDICAMENTS CONTAINING ANTIBIOTICS (EXCEPT PENICILLINS AND STREPTOMYCINS) EXCLUDING THOSE IN DOSAGE FORM OR RETAIL PACKINGS IMPORTS IN 2022
4.6.1 EXECUTIVE SUMMARY
4.6.2 AUSTRALIA
4.6.3 FRENCH POLYNESIA
4.6.4 NEW ZEALAND
4.6.5 PALAU
4.6.6 TONGA
4.7 THE MIDDLE EAST: MEDICAMENTS CONTAINING ANTIBIOTICS (EXCEPT PENICILLINS AND STREPTOMYCINS) EXCLUDING THOSE IN DOSAGE FORM OR RETAIL PACKINGS IMPORTS IN 2022
4.7.1 EXECUTIVE SUMMARY
4.7.2 ISRAEL
4.7.3 JORDAN
4.7.4 KUWAIT
4.7.5 OMAN
4.7.6 PAKISTAN
4.7.7 QATAR
4.7.8 TURKEY
4.7.9 YEMEN

5 DISCLAIMERS, WARRANTIES, AND USER AGREEMENT PROVISIONS
5.1 DISCLAIMERS & SAFE HARBOR
5.2 ICON GROUP INTERNATIONAL, INC. USER AGREEMENT PROVISIONS